Search

everythinglearnresearchcommunity

for

Search:↓

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

New small molecule drugs could help treat hair loss.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

The research created a model to understand human hair growth cycle, which can help diagnose and treat hair growth disorders and test potential hair growth drugs.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Polymeric nanoparticles could improve hair loss treatments by delivering drugs more effectively to hair follicles.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Niosomes are the most effective at delivering drugs to the skin with minimal absorption into the body.

Confocal Laser Scanning Microscopy (CLSM) is a useful tool for studying how drugs interact with skin and diagnosing skin disorders, despite some limitations.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Nanofiber scaffolds help wounds heal by delivering drugs directly to the injury site.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.